Elan drives market gains
In construction, CRH continued its recent good form climbing 29c to €34.75. Grafton jumped 11c to €11.77 while Kingspan was 4c higher at €21.24.
Elsewhere, shares in Elan soared by €2.17 to €13.87 after it confirmed it would conduct Phase 3 clinical trials of Alzheimer’s drug (AAB-001) in conjunction with partner Wyeth. Independent News & Media lost 2c to €3.64.